Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (434)	6/15/1999 12:30:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3158

>> Well we have a horizontal merger between two of the better UK 2nd/3rd tier biotechs - Celltech and Chiroscience. << Interesting...... Padfield gives up. Morale is low among CEOs in the sector. At least he's not caught in the headlights. Another "horizontal". I agree with others in the thread, they're not the best solution. However, they'll do, given some bright moments among those who are doing the planning. British biotech was traditionally more diversified, in a given company, than U.S. biotech. This is an attempt to maintain and enhance the tradition.